Style | Citing Format |
---|---|
MLA | Fallahi B, et al.. "Value of Two-Phase [68Ga]Ga-Psma Pet/Ct Imaging in Comparison With Optimized Delayed Imaging in Detecting Locoregional Prostatic Metastases." Iranian Journal of Nuclear Medicine, vol. 33, no. 1, 2025, pp. 27-36. |
APA | Fallahi B, Saidi B, Fardesfahani A, Beiki D, Emamiardekani A, Manafifarid R (2025). Value of Two-Phase [68Ga]Ga-Psma Pet/Ct Imaging in Comparison With Optimized Delayed Imaging in Detecting Locoregional Prostatic Metastases. Iranian Journal of Nuclear Medicine, 33(1), 27-36. |
Chicago | Fallahi B, Saidi B, Fardesfahani A, Beiki D, Emamiardekani A, Manafifarid R. "Value of Two-Phase [68Ga]Ga-Psma Pet/Ct Imaging in Comparison With Optimized Delayed Imaging in Detecting Locoregional Prostatic Metastases." Iranian Journal of Nuclear Medicine 33, no. 1 (2025): 27-36. |
Harvard | Fallahi B et al. (2025) 'Value of Two-Phase [68Ga]Ga-Psma Pet/Ct Imaging in Comparison With Optimized Delayed Imaging in Detecting Locoregional Prostatic Metastases', Iranian Journal of Nuclear Medicine, 33(1), pp. 27-36. |
Vancouver | Fallahi B, Saidi B, Fardesfahani A, Beiki D, Emamiardekani A, Manafifarid R. Value of Two-Phase [68Ga]Ga-Psma Pet/Ct Imaging in Comparison With Optimized Delayed Imaging in Detecting Locoregional Prostatic Metastases. Iranian Journal of Nuclear Medicine. 2025;33(1):27-36. |
BibTex | @article{ author = {Fallahi B and Saidi B and Fardesfahani A and Beiki D and Emamiardekani A and Manafifarid R}, title = {Value of Two-Phase [68Ga]Ga-Psma Pet/Ct Imaging in Comparison With Optimized Delayed Imaging in Detecting Locoregional Prostatic Metastases}, journal = {Iranian Journal of Nuclear Medicine}, volume = {33}, number = {1}, pages = {27-36}, year = {2025} } |
RIS | TY - JOUR AU - Fallahi B AU - Saidi B AU - Fardesfahani A AU - Beiki D AU - Emamiardekani A AU - Manafifarid R TI - Value of Two-Phase [68Ga]Ga-Psma Pet/Ct Imaging in Comparison With Optimized Delayed Imaging in Detecting Locoregional Prostatic Metastases JO - Iranian Journal of Nuclear Medicine VL - 33 IS - 1 SP - 27 EP - 36 PY - 2025 ER - |